Passlogix hits 500,000 user licenses milestone for single sign-on product

Passlogix, a provider of enterprise single sign-on systems, has sold 500,000+ licenses of its v GO Sign-On Platform products into the healthcare industry.
     
The Passlogix v-GO Sign-On Platform, built around v-GO Single Sign-On (v-GO SSO), helps enterprises strengthen security policies and practices, to simplify work processes, reduce costs and to simplify deployments of strong authentication and identity management system, the company said.
     
Besides v-GO SSO, the v-GO Sign-On Platform consists of v-GO Session Manager (v-GO SM) for shared workstations and kiosks, v-GO Self Service Password Reset (v-GO SSPR) for recovering a Windows password, v-GO Authentication Manager (v-GO AM) to enable universal sign-on for strong authenticators and v-GO Provisioning (v-GO PM) Manager for interoperability with all major provisioning systems.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.